Atlas Trials

Pioglitazone and Insulin Resistance in ADT

Clinical trial NCT05098327 · WITHDRAWN

Trial details

NCT number
NCT05098327
Sponsor
State University of New York at Buffalo
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate CancerInsulin ResistanceDiabetes Mellitus, Type 2Androgen Deficiency
Start date
2021-08-01
Primary completion
2023-03-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.